BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 34052835)

  • 1. Simultaneously targeting SOAT1 and CPT1A ameliorates hepatocellular carcinoma by disrupting lipid homeostasis.
    Ren M; Xu H; Xia H; Tang Q; Bi F
    Cell Death Discov; 2021 May; 7(1):125. PubMed ID: 34052835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting CPT1A-mediated fatty acid oxidation sensitizes nasopharyngeal carcinoma to radiation therapy.
    Tan Z; Xiao L; Tang M; Bai F; Li J; Li L; Shi F; Li N; Li Y; Du Q; Lu J; Weng X; Yi W; Zhang H; Fan J; Zhou J; Gao Q; Onuchic JN; Bode AM; Luo X; Cao Y
    Theranostics; 2018; 8(9):2329-2347. PubMed ID: 29721083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CPT1A-mediated Fat Oxidation, Mechanisms, and Therapeutic Potential.
    Schlaepfer IR; Joshi M
    Endocrinology; 2020 Feb; 161(2):. PubMed ID: 31900483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. iRGD-modified exosomes effectively deliver CPT1A siRNA to colon cancer cells, reversing oxaliplatin resistance by regulating fatty acid oxidation.
    Lin D; Zhang H; Liu R; Deng T; Ning T; Bai M; Yang Y; Zhu K; Wang J; Duan J; Ge S; Sun B; Ying G; Ba Y
    Mol Oncol; 2021 Dec; 15(12):3430-3446. PubMed ID: 34213835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carnitine palmitoyltransferase 1A functions to repress FoxO transcription factors to allow cell cycle progression in ovarian cancer.
    Shao H; Mohamed EM; Xu GG; Waters M; Jing K; Ma Y; Zhang Y; Spiegel S; Idowu MO; Fang X
    Oncotarget; 2016 Jan; 7(4):3832-46. PubMed ID: 26716645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD147 reprograms fatty acid metabolism in hepatocellular carcinoma cells through Akt/mTOR/SREBP1c and P38/PPARα pathways.
    Li J; Huang Q; Long X; Zhang J; Huang X; Aa J; Yang H; Chen Z; Xing J
    J Hepatol; 2015 Dec; 63(6):1378-89. PubMed ID: 26282231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Etomoxir Actions on Regulatory and Memory T Cells Are Independent of Cpt1a-Mediated Fatty Acid Oxidation.
    Raud B; Roy DG; Divakaruni AS; Tarasenko TN; Franke R; Ma EH; Samborska B; Hsieh WY; Wong AH; Stüve P; Arnold-Schrauf C; Guderian M; Lochner M; Rampertaap S; Romito K; Monsale J; Brönstrup M; Bensinger SJ; Murphy AN; McGuire PJ; Jones RG; Sparwasser T; Berod L
    Cell Metab; 2018 Sep; 28(3):504-515.e7. PubMed ID: 30043753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carnitine palmitoyltransferase 1A prevents fatty acid-induced adipocyte dysfunction through suppression of c-Jun N-terminal kinase.
    Gao X; Li K; Hui X; Kong X; Sweeney G; Wang Y; Xu A; Teng M; Liu P; Wu D
    Biochem J; 2011 May; 435(3):723-32. PubMed ID: 21348853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of carnitine palmitoyl transferase 1A-induced fatty acid oxidation suppresses cell progression in gastric cancer.
    Wang L; Li C; Song Y; Yan Z
    Arch Biochem Biophys; 2020 Dec; 696():108664. PubMed ID: 33157102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. P53 deficiency affects cholesterol esterification to exacerbate hepatocarcinogenesis.
    Zhu Y; Gu L; Lin X; Zhou X; Lu B; Liu C; Li Y; Prochownik EV; Karin M; Wang F; Li Y
    Hepatology; 2023 May; 77(5):1499-1511. PubMed ID: 35398929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CPT1A loss disrupts BCAA metabolism to confer therapeutic vulnerability in TP53-mutated liver cancer.
    Liu Y; Wang F; Yan G; Tong Y; Guo W; Li S; Qian Y; Li Q; Shu Y; Zhang L; Zhang Y; Xia Q
    Cancer Lett; 2024 May; 595():217006. PubMed ID: 38823763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of cannabinoid receptor 1 (brain) on lipid accumulation by transcriptional control of CPT1A and CPT1B.
    Zhang YF; Yuan ZQ; Song DG; Zhou XH; Wang YZ
    Anim Genet; 2014 Feb; 45(1):38-47. PubMed ID: 23914904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholesterol activates the Wnt/PCP-YAP signaling in SOAT1-targeted treatment of colon cancer.
    Xu H; Xia H; Zhou S; Tang Q; Bi F
    Cell Death Discov; 2021 Feb; 7(1):38. PubMed ID: 33637695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acetyl-coenzyme A carboxylase alpha promotion of glucose-mediated fatty acid synthesis enhances survival of hepatocellular carcinoma in mice and patients.
    Wang MD; Wu H; Fu GB; Zhang HL; Zhou X; Tang L; Dong LW; Qin CJ; Huang S; Zhao LH; Zeng M; Wu MC; Yan HX; Wang HY
    Hepatology; 2016 Apr; 63(4):1272-86. PubMed ID: 26698170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting sterol-O-acyltransferase 1 to disrupt cholesterol metabolism for cancer therapy.
    Tu T; Zhang H; Xu H
    Front Oncol; 2023; 13():1197502. PubMed ID: 37409263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver CPT1A gene therapy reduces diet-induced hepatic steatosis in mice and highlights potential lipid biomarkers for human NAFLD.
    Weber M; Mera P; Casas J; Salvador J; Rodríguez A; Alonso S; Sebastián D; Soler-Vázquez MC; Montironi C; Recalde S; Fucho R; Calderón-Domínguez M; Mir JF; Bartrons R; Escola-Gil JC; Sánchez-Infantes D; Zorzano A; Llorente-Cortes V; Casals N; Valentí V; Frühbeck G; Herrero L; Serra D
    FASEB J; 2020 Sep; 34(9):11816-11837. PubMed ID: 32666604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Berberine Protects Against Palmitate-Induced Apoptosis in Tubular Epithelial Cells by Promoting Fatty Acid Oxidation.
    Sun J; Chen X; Liu T; Jiang X; Wu Y; Yang S; Hua W; Li Z; Huang H; Ruan X; Du X
    Med Sci Monit; 2018 Mar; 24():1484-1492. PubMed ID: 29528039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of the hepatic malonyl-CoA-carnitine palmitoyltransferase 1A partnership creates a metabolic switch allowing oxidation of de novo fatty acids.
    Akkaoui M; Cohen I; Esnous C; Lenoir V; Sournac M; Girard J; Prip-Buus C
    Biochem J; 2009 May; 420(3):429-38. PubMed ID: 19302064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular therapy for obesity and diabetes based on a long-term increase in hepatic fatty-acid oxidation.
    Orellana-Gavaldà JM; Herrero L; Malandrino MI; Pañeda A; Sol Rodríguez-Peña M; Petry H; Asins G; Van Deventer S; Hegardt FG; Serra D
    Hepatology; 2011 Mar; 53(3):821-32. PubMed ID: 21319201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired fatty acid oxidation as a cause for lipotoxicity in cardiomyocytes.
    Haffar T; Bérubé-Simard F; Bousette N
    Biochem Biophys Res Commun; 2015 Dec 4-11; 468(1-2):73-8. PubMed ID: 26546819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.